Cedazuridine
ATC — · 6 markets · 8 records
AU 3 records · 2 strengths
- 100 mgtabletINQOVIINQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack
Records without a stated strength · 1 INQOVI
US 1 records · 1 strengths
- 100 mgtabletINQOVI
GB 1 records · 1 strengths
- 100 mgtabletInaqovi 35mg/100mg tablets
CA 1 records · 1 strengths
- 100 mgtabletINQOVI
ES 1 records · 1 strengths
- 100 mgtabletInaqovi 35mg/100mg tablets
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Inaqovi 35mg/100mg tablets
| Strength / form / release | US | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|---|
| 100 mg tablet | INQOVI | Inaqovi 35mg/100mg tablets | INQOVI | INQOVI INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack | Inaqovi 35mg/100mg tablets | |
unknown | INQOVI | Inaqovi 35mg/100mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.